intestine, eliminating carcinogenic factors, enhancing immunity, and lowering cholesterol (Farnworth, 2008) . Previous research works indicated that Lactobacillus gasseri PA3 has the ability to reduce purines, including inosine 5′-monophosphate (IMP), inosine, hypoxanthine, guanosine 5′-monophosphate (GMP), and guanosine in rats, but L. gasseri OLL2996 does not have the ability to absorb purines Yamada et al., 2016 Yamada et al., , 2018 Yamada et al., , 2017 . Further study shows that L. gasseri PA3 can lower serum uric acid levels even in patients with hyperuricemia and gout (Yamanaka, Taniguchi, Tsuboi, Kano, & Asami, 2018) , which is caused by decrease of uric acid excretion or increase of uric acid accumulation because of abnormal purine metabolism (Richette & Bardin, 2010) . In Japan, daily intake of dietary purines is recommended to be less than 400 mg to prevent gout and hyperuricemia (Kaneko, Aoyagi, Fukuuchi, Inazawa, & Yamaoka, 2014) . Recent study of L. gasseri PA3 offers a new breakthrough in preventing gout, and not just relying on a controlled diet with less purine. However, the question of how PA3 will influence gut microbiota remains unclear.
PA3 enters the small intestine to weaken the absorption of exogenous purines. The arrival of new species will definitely affect other microorganisms and their metabolism. Irrespective of whether it can colonize the intestine or not, a new steady state of microbial community will be formed, to build a potential barrier against hyperuricemia and gout. This research on the change of intestinal microbial composition and metabolism induced by L. gasseri PA3 having an ability to adsorb purine has been undertaken, which can be a guideline for the development of an effective treatment for hyperuricemia and gout.
| MATERIAL S AND ME THODS

| Preparation of Lactobacillus gasseri PA3 supplements (LGS)
Lactobacillus gasseri PA3 with an ability of purine absorption was isolated from Lactobacillus gasseri PA3 drinking yogurt (Meiji) by the method of Jang et al. (2013) and cultured in Man Rogosa Sharpe (MRS) liquid medium at 37°C for 48 hr. MRS (g/L): peptone 10.0, beef extract 5.0, glucose 20.0, Tween 80 1.0, dipotassium phosphate 2.0, sodium acetate 5.0, triammonium citrate 2.0, magnesium sulfate 0.2, manganese sulfate 0.05, and agar powder 14.5. After 15 min of centrifugation at 6,000g, supernatant was discarded and isometric fermented nutritive medium (FNM) was added to suspend the cells. FNM (g/L) is composed of: peptone 3.0, corn starch 8.0, yeast extract 4.5, tryptone 3.0, Mucin 0.5, l-cysteine hydrochloride 0. 
| Fecal sample collection and pretreatment
Fecal samples were donated by six healthy adult women, aged 20-30 years, who did not have inflammatory bowel disease and irritable bowel syndrome, and did not receive antibiotics for at least 6 months. The above fecal samples were voluntarily provided by volunteers and informed consent was signed. Ten grams of fresh fecal samples were collected and microorganisms were fully suspended in 90 ml of sterile PBS (0.1 M, pH = 6.8) by stirring well. Then the suspension was filtered by a sterile gauze and made into microbial suspension. The whole operation was carried out in an anaerobic environment.
| In vitro single-stage colonic fermentation
In vitro single-stage colonic fermentation was conducted in Changdao Moni simulation system (CDMNS) at Zhejiang Gongshang University. About 10% of fecal microbiota (v/v) was inoculated into first-stage ( Figure 1 ) fermentation reactors with 600 ml FNM. The fermentation system approached stability after 7 days, and fermentation liquid was equally pumped into 2 reactors (second stage). One was supplied with 30 ml LGS (L) while the other was supplemented with an equivalent volume of FNM (control group [C]) on the first day of second-stage process. During the entire fermentation process, the speed of stirring rotor was set at 120 r/min and maintained uniformly throughout the experiment. All the reactors were kept at 37°C, and 0.5 M NaOH and HCl were utilized to maintain pH values at 6.8. Nitrogen gas with a speed of 0.1 L/min was passed into every vessel for 30 min every morning, noon, and night to maintain an anaerobic environment. The consecutive fed-batch fermentations were used by replacing nutrient medium at a flow speed of 37.5 ml/ hr and were conducted for 24 hr per cycle. In the meantime, fermentation liquor was wasted out at a same velocity to balance the total amount of medium in the reactor. The samples of second stage were collected every 24 hr after supplementation for 8 days and kept at −20°C. The experiments were repeated in triplicate.
| Short-chain fatty acid assay
A volume of 0.5 ml of fermentation supernatant was taken from each sample and filtered through 0.22 μm filter membrane after F I G U R E 1 The schematic graph of in vitro single-stage colonic simulation, each small square represents 1 day. First stage: stable period (F1-F7); second stage: Lactobacillus gasseri PA3 supplemental period (S1-S8, group L is supplemented with L. gasseri PA3 and group C with FMN as control group). Samples were collected and analyzed from day S1 to day S8 centrifugation at 9570g for 2 min. The collected supernatant was again centrifuged at 10,000g for 5 min after thoroughly mixing with 10 ml of ethyl ether and 0.05 ml of sulfuric acid solution (50%). The mixture solution was investigated by gas chromatography-mass spectrometry (GC-MS: 7890A-5975C; Agilent) analysis with the following operating conditions: free fatty acid phase (FFAP) elastic quartz capillary column (30 m × 0.25 mm × 0.25 µm); carrier gas: 2 ml/min high purity nitrogen (≥99.999%); ion source type for mass spectrometer: electrospray ion source; ion source temperature:
350°C; interface temperature: 250°C; inlet temperature: 270°C; detector temperature (FID): 280°C; and injection volume: 2.0 μl. Purified amplicons were pooled in equimolar and paired-end sequenced (2 × 300) on an Illumina MiSeq platform (Illumina) according to the standard protocols by LC-Bio Technology Co. Ltd.16S rRNA gene sequences were processed as we previously described (Xu et al., 2018) .
| DNA extraction, PCR amplification, and 16S rRNA gene analysis
| Statistics
All data are shown as the mean ± SD. The data were analyzed by variance and Duncan's test for multiple comparisons with SPSS ver. 17.0.
A value of p < .05 was considered significant.
| RE SULTS
| Effect of Lactobacillus gasseri PA3 on bacteria community
A total of 45 samples from two groups, with/without L. gasseri PA3, were chosen for microorganism profile analyses. After quality filtering, the 16S rRNA sequencing results produced 9,317,346 reads, giving a mean sample depth of 99,120 reads with a standard deviation of 79,078 reads. A total of 814 operational taxonomic units (OTUs) were obtained, and the relative abundance of OTUs showed the genera relative abundances in the samples. Chao1 and observed OTUs are two indices to indicate abundance and diversity of microbial community. As shown in Figure 2 , diversities of the microorganisms in the L group were significantly lower than those in the C group. (Figure 6) , the difference between the L. gasseri group and the control group was obvious. The pattern of inter-group differences was similar to that shown in the PCA result.
| Effect of Lactobacillus gasseri PA3 on shortchain fatty acids
The total concentration of short-chain fatty acids in the L. gasseri group was lower than that in the control group, but both groups showed a parabolic shape of short-chain fatty acid (SCFA) content. The concentration of propionate and pentanoate in the L. gasseri group was almost difficult to detect. The concentration of acetate and butyrate was low, but their proportion was higher. The level of acetate in the L. gasseri group was lower in the second-stage fermentation than in the control group, and the concentration of acetate in the L. gasseri group reached the peak on the fourth day. During the first 6 days, butyrate concentration in the L. gasseri group was lower than that in the control group, and a reverse trend was observed in the last two days, which reached the peak on the seventh day. Acetate and butyrate showed a negative correlation between each other (Figure 7) . F I G U R E 3 Principal components analysis of samples collected during 8 days of in vitro colonic simulation. The weight coefficients of PC1 and PC2 are 42.58% and 38.79%, respectively F I G U R E 4 Effect of Lactobacillus gasseri on bacterial phylum alternation during the 8 days. C stands for control group, L stands for L. gasseri group, and figures stand for the day
| Relationship between samples, microbiota, and SCFAs via canonical correspondence analysis
We found that nearly half of the bacteria are positively related to the metabolism of acetate and butyrate, while most of the bacteria are extensively related to propionate and pentanoate. Here, we also found that Escherichia, Lactobacillus, Clostridium, and Citrobacter had a negative correlation with SCFAs in this simulation. Samples of L. gasseri group were mainly concentrated in the lower right region.
Due to the rich species diversity, the control group and most of the microorganisms mainly fell in the upper left block. The samples collected on the first and the last day of the two groups were similarly located in the upper right block (Figure 8 ).
| Metabolism and function prediction of gut microbial community
16S rRNA marker gene sequences were used to predict functional profiling of microbial communities, 41 secondary metabolic pathways, and 327 tertiary metabolic pathways of Kyoto Encyclopedia (Table S1 ). After eight days of metabolism prediction, the metabolism of L group was lower than that of group C. Twenty-six secondary pathways show significant differences between the two groups. The most significant observation was that the amino acid metabolism in L. gasseri group was reduced.
Moreover, important pathways related to energy metabolism, carbohydrate metabolism, and metabolism of cofactors and vitamins were all reduced in contrast to control group, while membrane transport increased (Figure 9 ). The results of tertiary metabolic pathways show that nucleotide metabolism is stronger in group L. Although nucleotide metabolites such as purines are very threatening to gout, the purine metabolism pathway, which is the production pathway of uric acid, in the group L was weaker than that in the group C, especially on the second day ( Figure 10 ).
| D ISCUSS I ON
In this study, in vitro colonic simulation of L. gasseri PA3 digestion showed that dietary intake of Lactobacillus led to a significant change of intestinal microbe composition and that Lactobacillus became dominant bacteria at later stages, thus decreasing microbial diversity. Due to specificities of individuals, gut microbiota varies widely F I G U R E 7 Effect of Lactobacillus gasseri on short-chain fatty acids during the 8-day simulation period (mg/ml) F I G U R E 8 Canonical correspondence analysis. Cycles stand for samples, triangles stand for genus, and arrows stand for different short-chain fatty acids. The closer the two points, the higher was the similarity of a community structure of two samples. Arrows suggested distinct factors of influences. When an angle between influencing factors (or between factors and samples) was an acute angle, these two factors were positively correlated. On the contrary, an obtuse angle had a negative correlation. The longer the ray, the heavier was the effects of factors and showed a high degree of dynamism, but intestinal microbiota of individuals consisted of Firmicutes and Proteobacteria, which occupy 80%-90% of the relative abundance of the intestinal flora (Park, Omura, Fujita, Sato, & Tsunoda, 2017) . However, overdoses of L. gasseri PA3 caused the irreversible decrease of Bacteroides. In the late fermentation stage, the relative abundance of Proteobacteria was gradually increased by nearly 50%, and Lactobacillus gradually decreased, indicating that Lactobacillus and Escherichia had a certain competitive relationship. We also observed that Lactobacillus was recovered on the sixth day, and Clostridium and Escherichia were reduced. This rebound phenomenon observed in the relative abundance of Lactobacillus may indicate that Lactobacillus began to adapt F I G U R E 9 Comparisons of the predominant gene pathways of the bacterial microbiota in different groups as predicted by PICRUSt. Green stands for Lactobacillus gasseri group and brown stands for control group F I G U R E 1 0 Nucleotide metabolism (a) and purine metabolism (b) of tertiary metabolic pathways of Kyoto Encyclopedia of Genes and Genome as predicted by PICRUSt to the competition in intestine and started to reproduce. However, previous studies by Prilassnig, Wenisch, Daxboeck, and Feierl (2007) found that L. gasseri could not be detected in feces after one week, after probiotics were administered to healthy individuals. In this study, we found that L. gasseri can survive and reproduce in the ascending colon portion.
Dietary fiber, proteins, and peptides are metabolized by the microbiota of the cecum and colon after escaping from host enzyme digestion. The main products of microbial fermentation activity in the gut are SCFAs (Macfarlane & Macfarlane, 2012) . SCFAs can directly activate G-coupled receptors, inhibit histone deacetylases, and act as an energy source for small intestinal epithelial cells. Therefore, they affect various physiological processes and may lead to health and diseases (Koh, De Vadder, Kovatcheva-Datchary, & Bäckhed, 2016) . Butyrate is the energy source for small intestinal epithelial cells, and it can also exhibit anti-inflammatory effects by blocking NF-κB activation, which is considered a potential substitute for antibiotics (Canfora, Jocken, & Blaak, 2015) . Acetate is the major metabolite of most bacterial glycolytic pathways in the intestine and is the first short-chain fatty acid found in the intestinal tract of newborns. An in vitro study of the effect of physiological concentrations of short-chain fatty acids on intestinal mucosal barrier in neonatal rats showed that physiological concentrations of acetic acid are more effective in maintaining normal intestinal mucosal barrier function than those of butyrate, and that acetate can be metabolized by various intestinal microbes, including
Bifidobacteria (Li et al., 2015) . Although the relative abundance of Bifidobacteria in this study did not belong to top 20 genera, there was a significant difference between two groups (p < .01), indicating more acetate was produced from Bifidobacteria in the control group. Propionate absorbed by the colon is mainly metabolized by the liver, participates in gluconeogenesis, and inhibits cholesterol synthesis (Backhed et al., 2004) . Propionic acid is mainly produced by Bacteroidetes and Firmicutes via the succinic acid metabolic pathway (Yamanaka et al., 2018 (Koh et al., 2016) . The large amount of Lactobacillus may weaken the formation of acetate while it might strengthen the production of lactate.
Metabolic and functional predictions of gut microbiota showed that the amino acid metabolism of the gut microbiota was significantly decreased in the gut environment where L. gasseri PA3 was abundantly present. Nucleotide metabolism was stronger in the group L which was characterized by tertiary metabolic pathways.
Although nucleotide metabolites such as purines are much threatening to gout, the purine metabolism pathway, which is the production pathway of uric acid, was weaker in the group L than in the group C, especially on the second day.
We propose that L. gasseri PA3 exerted an effect by reducing uric acid concentration by weakening the metabolism of purines, which may be similar to the mechanism of previous report which demonstrated a decrease in the uric acid production by interfering with purine metabolic pathway (Yang & Yuan, 2013) . This mechanism is different in Lactobacillus bulgaricus which first absorbs uric acid and then degrades it (Bai, Jiang, & Jiang, 2014) . However, weather purines in the intestine can be reduced like a mechanism reported by Yamada et al. (2017 Yamada et al. ( , 2018 remains unclear and needs further study.
Lactobacillus gasseri PA3 can reduce purines of intestine in rats and lower serum uric acid levels in patients.The pathway further validates the role of L. gasseri PA3 in preventing and relieving gout, which is of great significance for the prevention and treatment of hypertension, hyperlipidemia, heart disease, diabetes, and cancer (Farnworth, 2008; Koh et al., 2016) . In this study, L. gasseri PA3 can survive and play a role in the ascending colon environment.
Therefore, the evaluation of the effect of L. gasseri PA3 on intestinal microbes and their metabolisms has great guiding significance for the development of treatment to prevent gout.
The evaluation of probiotics is often done through the combination of external model, animal test, and clinical trial. Although in vitro fermentation model is fast and economical, it is widely used to assess the potential of probiotics in large quantities of foods that contain probiotics, and to ensure the effectiveness of the animal and clinical research. 
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